Status:
COMPLETED
Long Term Use of Somatropin in Patients Small for Gestational Age
Lead Sponsor:
Pfizer
Conditions:
Small for Gestational Age
Eligibility:
All Genders
Brief Summary
The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in thi...
Detailed Description
All the patients whom an investigator prescribes the first Genotropin® should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into ...
Eligibility Criteria
Inclusion
- Patients need to be administered Somatropin (Genotropin®) in order to be enrolled in the surveillance.
Exclusion
- Patients not administered Somatropin (Genotropin®).
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
920 Patients enrolled
Trial Details
Trial ID
NCT00793325
Start Date
February 1 2009
End Date
December 1 2012
Last Update
February 6 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.